Medtronic (MDT) Tops Q3 EPS by 4c; raises FY24 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Medtronic (MDT) gains after boosting full-year guidance
February 20, 2024 7:18 AM ESTMedtronic (NYSE: MDT) shares rose 4.25% after the medical device maker reported third-quarter earnings that topped analyst estimates and raised its revenue and earnings guidance for fiscal year 2024. The company's adjusted EPS of $1.30 was $0.04 higher than the consensus estimate of $1.26, while revenue for the quarter came in at $8.1 billion, surpassing the $7.95 billion expected by analysts.
The reported revenue marked a 4.7% increase on a... More
